propiolactone and Coxsackie Virus Infections

propiolactone has been researched along with Coxsackie Virus Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, Y; Huang, X; Huang, Z; Ku, Z; Li, D; Liu, Q; Zhang, Y1
Chao Zhang, Y; Guo Su, Z; Li, Q; Ping Yang, B; Qi An, W; Shi, L; Wen Pan, R1

Other Studies

2 other study(ies) available for propiolactone and Coxsackie Virus Infections

ArticleYear
Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.
    Vaccine, 2013, Apr-26, Volume: 31, Issue:18

    Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Chlorocebus aethiops; Coxsackievirus Infections; Disease Models, Animal; Enterovirus; Female; Immunization, Passive; Interferon-gamma; Mice; Mice, Inbred ICR; Neutralization Tests; Propiolactone; T-Lymphocytes; Vaccination; Vaccines, Inactivated; Vero Cells; Viral Vaccines

2013
The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems.
    Human vaccines & immunotherapeutics, 2014, Volume: 10, Issue:3

    Topics: Animals; Antibodies, Viral; Coxsackievirus Infections; Disinfectants; Dose-Response Relationship, Immunologic; Enterovirus; Female; Immunity, Maternally-Acquired; Immunization, Passive; Lethal Dose 50; Macaca fascicularis; Mice, Inbred BALB C; Propiolactone; Rats, Sprague-Dawley; Survival Analysis; Vaccines, Inactivated; Viral Vaccines; Virus Inactivation

2014